| ADRO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ADRO shares outstanding history going back to 4/15/2015:
Also see: ADRO Market Cap History ADRO YTD Return |
ADRO Shares Outstanding History — Aduro Biotech Share Count Over Time
As of 10/2/2020 Aduro Biotech has 16.21 million ADRO shares outstanding. Investors often track the ADRO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ADRO share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 4/15/2015.
| ADRO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
ADRO Historical Shares Outstanding: +6.60% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| ADRO Stock Price Chart |
| About Chinook Therapeutics Inc |
| Aduro Biotech is an immunotherapy company focused on the discovery, development and commercialization of therapies for the treatment of patients with diseases. Co.'s product candidates in the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL) pathways are being investigated in cancer, autoimmune and inflammatory diseases. Co.'s key STING pathway activator product candidate, ADU-S100 (MIW815), is designed to selectively modulate innate and adaptive immune responses to enhance immune control in oncology. Co.'s anti-APRIL antibody product candidate, BION-1301, is designed to suppress the autoimmune response in patients with IgA nephropathy. We show 24 historical shares outstanding datapoints in our coverage of ADRO's shares outstanding history. Understanding the changing numbers of ADRO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADRO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADRO by allowing them to research ADRO shares outstanding history as well as any other stock in our coverage universe. |
| ADRO Current Stock Quote |
Quotes delayed 20 minutes  Free ADRO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ADRO Share Performance |
| Shares Outstanding Peers |
| Aduro Biotech (ADRO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ADTX Shares Outstanding History ADUS Shares Outstanding History ADVM Shares Outstanding History ADXS Shares Outstanding History ADYX Shares Outstanding History AEMD Shares Outstanding History AERI Shares Outstanding History AEZS Shares Outstanding History AFIB Shares Outstanding History AGEN Shares Outstanding History More Healthcare companies » |
ADRO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
